Session 4: Cervical and Vulvar Cancer | DAY 2 - July 2nd, 2021 - 10:50-12:05 CEST

ESGO eAcademy, Faculty / Presenters, 333231

Session 3: Endometrial Cancers

ESGO eAcademy, Faculty / Presenters, 333230

Molecular and genetic characteristics of Trophoblastic tumours

ESGO eAcademy, Baljeet Kaur, 333229

Immuno-targeted therapy of Endometrial Cancer

ESGO eAcademy, Judith Kroep, 333228

Using the molecular classification of Endometrial Cancers to select adjuvant therapies

ESGO eAcademy, Carien Creutzberg, 333227

Lynch Syndrome, DNA repair genes, microsatellite instability and hormonal drivers in the development of Endometrial cancer

ESGO eAcademy, Naveena Singh, 333226

New molecular classification of Endometrial cancers: routine pathology diagnostics in endometrioid and non-endometrioid cancers?

ESGO eAcademy, Tjalling Bosse, 333225

Introduction

ESGO eAcademy, Faculty / Presenters, 333224

Session 3: Endometrial Cancers | DAY 2 - July 2nd, 2021 - 8:30-10:50 AM CEST

ESGO eAcademy, Faculty / Presenters, 333222

Session 2: Rare Gynaecological Tumours

ESGO eAcademy, Faculty / Presenters, 333221

Pathology and Molecular characteristics of Germ Cell tumours

ESGO eAcademy, Baljeet Kaur, 333220

Molecular and Genetic identifiers of Clear Cell Tumours as potential therapeutic targets

ESGO eAcademy, Xavier Matias-Guiu, 333219

Molecular and genetic pathways and characteristics of low-grade cancers (serous and others)

ESGO eAcademy, Glenn McCluggage, 333218

Introduction

ESGO eAcademy, Faculty / Presenters, 333217

Session 2: Rare Gynaecological Tumours | DAY 1 - July 1st, 2021 - 11:20-12:35 CEST

ESGO eAcademy, Faculty / Presenters, 333215

Welcome Message

ESGO eAcademy, Faculty / Presenters, 333204

Session 1: Molecular Markers in High Grade Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 333214

Targeting HR Deficiency- when and with which agents?

ESGO eAcademy, Jonathan Ledermann, 333213

Homologous Recombination Repair - How should HRD be determined and is it clinically useful? (incl. ovarian and endometrial cancers)

ESGO eAcademy, Xavier Matias-Guiu, 333212

Angiogenic pathways- significance in ovarian cancer and role of targeted anti-angiogenic therapy

ESGO eAcademy, Jonathan Ledermann, 333211

Conference Program

ESGO eAcademy, Faculty / Presenters, 330729

CA125 and serological markers of ovarian cancer- Anything new in last decade?

ESGO eAcademy, Fagotti Anna, 333210

BRCA mutations – Pathological and Variants of unknown significance and other genes associated with hereditary ovarian cancer

ESGO eAcademy, Naveena Singh, 333209

P53 mutations, Precursor lesions mutations and immunological markers- what do they signify?

ESGO eAcademy, Glenn McCluggage, 333208

Introduction

ESGO eAcademy, Faculty / Presenters, 333207

Session 1: Molecular Markers in High Grade Ovarian Cancer | DAY 1 - July 1st, 2021 - 08:30-11:20 CEST

ESGO eAcademy, Faculty / Presenters, 333205

SLN mapping in endometrial cancer

ESGO eAcademy, Faculty / Presenters, 330580

Removal of the upper lymphovascular paracervical tissue as a part of a pelvic SLN algorithm

ESGO eAcademy, Jan Persson, 333322

Robotic paraaortic SLN detection following injection of ICG in the IP-ligaments

ESGO eAcademy, Jan Persson, 333321

Robot-assisted transperitoneal paraaortic lymphadenectomy

ESGO eAcademy, Henrik Falconer, 333319

Sentinel lymph node detection along the lower paracervical lymphatic pathway

ESGO eAcademy, Jan Persson, 333318

Tips and Trick for Obese Patients: Robotic Transperitoneal Aortic Lymphadenectomy

ESGO eAcademy, Jordi Ponce, 333316

Cervical cancer elimination - it is possible or not?

ESGO eAcademy, Faculty / Presenters, 333260

Pelvic anatomy for gynecologic oncologists: Autonomic bladder plexus

ESGO eAcademy, Faculty / Presenters, 332162

Pelvic sentinel node detection along the upper paracervical pathway

ESGO eAcademy, Jan Persson, 332138

Paraaortic mapping NIF Firefly: ICG mediated visualization of paraaortic compartmental lymph nodes

ESGO eAcademy, Rainer Kimmig, 332137

Robotic assisted laparoscopic paraaortic access and lymphadenectomy in 10 steps

ESGO eAcademy, Delphine HUDRY, 332136

What do the patients expect from us? An anthropological perspective

ESGO eAcademy, Luis Chiva, 332135

HIPEC and the biologic rationale

ESGO eAcademy, O. Zivanovic, 330601

Image-guided surgery

ESGO eAcademy, Alexander L. Vahrmeijer, 330600

HRD testing in ovarian cancer

ESGO eAcademy, Anniina Farkkila, 330599

Role of maintenance therapy

ESGO eAcademy, Christian Marth, 330598

Genetic profiling for the management of ovarian cancer

ESGO eAcademy, Sandro Pignata, 330597

Cervical cancer in pregnancy

ESGO eAcademy, Frederic Amant, 330595

New classification approaches for cervical carcinoma

ESGO eAcademy, Ben Davidson, 330594

Targeted therapies in endometrial carcinoma: Where we are?

ESGO eAcademy, Isabelle Ray-Coquard, 330593

Implementing molecular endometrial cancer classification in clinic

ESGO eAcademy, Tjalling Bosse, 330592

Registration form

ESGO eAcademy, Faculty / Presenters, 330581

Thoracic anatomical landmarks and VATS cardiophrenic lypmh node resection in advanced ovarian cancer

ESGO eAcademy, Faculty / Presenters, 330161

Tumour Board 7: Management of Cervical Cancer Patients

ESGO eAcademy, Faculty / Presenters, 330160

Role of PARP inhibitors in Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 330132

Step 1: Registration form

ESGO eAcademy, Faculty / Presenters, 325813

Right upper abdomen debulking in ovarian cancer

ESGO eAcademy, Faculty / Presenters, 325811

Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study

ESGO eAcademy, Gloria Salvo, 324034

Uterine manipulator in endometrial cancer: a video is worth a thousand words

ESGO eAcademy, Faculty / Presenters, 322741

Introduction to Robotics: overview the benefits of robotics in GO

ESGO eAcademy, Faculty / Presenters, 318220

Tumour Board 6: Management of Ovarian Cancer Patients

ESGO eAcademy, Faculty / Presenters, 322683

Modern surgical staging for endometrial cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 322378

ENYGO LiFE Report - 12th edition

ESGO eAcademy, Faculty / Presenters, 322377

Modern surgical staging for endometrial cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 321298

Extraperitoneal paraaortic lymphadenectomies

ESGO eAcademy, Faculty / Presenters, 315511

COVID-19 Vaccination for patients under the cancer therapy

ESGO eAcademy, Faculty / Presenters, 318267

On-Demand - Introduction to Robotics: overview the benefits of robotics in GO

ESGO eAcademy, Faculty / Presenters, 318219

Right upper quadrant peritonectomy - FAQ

ESGO eAcademy, Artem Stepanyan, 315632

Right upper quadrant peritonectomy - Transperitoneal Approach

ESGO eAcademy, Artem Stepanyan, 315631

Right upper quadrant peritonectomy - Retroperitoneal Approach

ESGO eAcademy, Artem Stepanyan, 315630

Complete tumor resection from porta hepatis in a patient with recurrent epithelial ovarian cancer

ESGO eAcademy, Faculty / Presenters, 315629

The new ESGO-ISUOG-ESGE-IOTA consensus on the pre-operative assessment of ovarian and tubal pathology

ESGO eAcademy, Christina Fotopoulou, 315526

Step 1: Registration

ESGO eAcademy, Faculty / Presenters, 315512

Uterine transposition for uterine preservation

ESGO eAcademy, Faculty / Presenters, 314426

Tumour Board 5: Cancer in Pregnancy

ESGO eAcademy, Faculty / Presenters, 315062

Gynaecological Cancer during pregnancy, with an emphasis on chemotherapy

ESGO eAcademy, Frederic Amant, 314824

Uterine Transposition: Robotic uterine transposition for a cervical cancer patient with pelvic micrometastases after conization and pelvic lymphadenectomy

ESGO eAcademy, Faculty / Presenters, 314787

Inspiring leaders interview with prof. Ignace Vergote

ESGO eAcademy, Agnieszka Rychlik, 314762

Radical hysterectomy step by step

ESGO eAcademy, Faculty / Presenters, 314118

Step 1 - Registration for Uterine transposition for uterine preservation

ESGO eAcademy, Faculty / Presenters, 314427

Open Surgery is the NEW Standard of Care: PRO

ESGO eAcademy, Pedro Ramirez, 314408

Open Surgery is the NEW Standard of Care: CON

ESGO eAcademy, Mario Leitao Jr., 314407

Surgery in recurrent ovarian cancer? CON

ESGO eAcademy, Coleman Robert, 314406

Surgery in recurrent ovarian cancer? PRO

ESGO eAcademy, Andreas du Bois, 314405

Systemic therapy in cervical cancer: from antiangiogenic to immunotherapy

ESGO eAcademy, Domenica Lorusso, 314404

FIGO classification and its impact on management

ESGO eAcademy, René Pareja, 314403

Radiotherapy options in advanced cervical cancer. Is there role of neoadjuvant chemotherapy?

ESGO eAcademy, Alejandra Martinez, 314402

Risk groups or molecular profile: what should we do from now on?

ESGO eAcademy, Xavier Matias-Guiu, 314401

Adjuvant radiotherapy in endometrial cancer

ESGO eAcademy, Anuja Jhingran, 314400

PARPi in front line: current challenges and future directions

ESGO eAcademy, AINHOA MADARIAGA, 314399

Step 1 - Registration

ESGO eAcademy, Faculty / Presenters, 314119

State of the Art ESGO Conference Closing Remarks

ESGO eAcademy, Faculty / Presenters, 313678

Open vs MIS approach for radical hysterectomy and radical hysterectomy: limits and challenges

ESGO eAcademy, Pedro Ramirez, 312881

Decision making processes, patients selection and allocation of healthcare resources in times of crisis

ESGO eAcademy, Nadeem R. Abu-Rustum, 312527

Establishing SLN as standard of care in endometrial and cervical cancer?

ESGO eAcademy, Denis Querleu, 312526

FIGO stage IV and metastatic endometrial cancer

ESGO eAcademy, Christian Marth, 312525

Endometrial cancer , stage IV and metastatic. Set up the case

ESGO eAcademy, Mansoor Raza Mirza, 312524

Endometrial cancer adjuvant therapy. State of the art lecture

ESGO eAcademy, Domenica Lorusso, 312523